Most 'slow responders' to tirzepatide achieve 5% or greater weight reduction at 72 weeks

Nearly all adults who lose less than 5% of their body weight with tirzepatide at 12 weeks were able to achieve at least a 5% weight loss by 72 weeks, according to a post-hoc analysis of the SURMOUNT-1 trial.

Source: Healio

View More